Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Clinical Interventions in Aging|November 11, 2017
Clostridium difficile infection in the elderly: an update on managementTomefa E Asempa, David P Nicolau
Expert Review of Anti-Infective Therapy|December 7, 2024
Unraveling sulbactam-durlobactam: insights into its role in combating infections caused by Acinetobacter baumanniiYakun Fu, Tomefa E Asempa, Joseph L Kuti
The Journal of Antimicrobial Chemotherapy|January 14, 2020
Metallo-β-lactamase resistance in Enterobacteriaceae is an artefact of currently utilized antimicrobial susceptibility testing methodsTomefa E Asempa, Kamilia Abdelraouf, David P Nicolau
Antimicrobial Agents and Chemotherapy|March 30, 2021
Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing Enterobacterales in Animal Infection Models: a Current State of AffairsTomefa E Asempa, Kamilia Abdelraouf, David P Nicolau
The Journal of Antimicrobial Chemotherapy|November 8, 2021
Clinical exposure-response relationship of cefepime/taniborbactam against Gram-negative organisms in the murine complicated urinary tract infection modelMaxwell J Lasko, David P Nicolau, Tomefa E Asempa
Antibiotics (Basel, Switzerland)|March 6, 2021
Pharmacodynamics of Ceftibuten: An Assessment of an Oral Cephalosporin against Enterobacterales in a Neutropenic Murine Thigh ModelMaxwell J Lasko, Tomefa E Asempa, David P Nicolau
Antimicrobial Agents and Chemotherapy|May 20, 2020
Human-Simulated Antimicrobial Regimens in Animal Models: Transparency and Validation Are ImperativeChristian M Gill, Tomefa E Asempa, David P Nicolau
Antimicrobial Agents and Chemotherapy|July 3, 2019
In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosaTomefa E Asempa, David P Nicolau, Joseph L Kuti
Pageof 5